Total Payments
$21,933
2024 Payments
$3,291
Companies
80
Transactions
1,100
Medicare Patients
36,771
Medicare Billing
$13.4M
Payment Breakdown by Category
Food & Beverage$19,130 (87.2%)
Education$1,522 (6.9%)
Other$1,281 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,130 | 1,054 | 87.2% |
| Education | $1,522 | 32 | 6.9% |
| Long term medical supply or device loan | $1,281 | 14 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,232 | 117 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,256 | 77 | $0 (2024) |
| Genentech USA, Inc. | $1,196 | 74 | $0 (2024) |
| Astellas Pharma US Inc | $904.99 | 43 | $0 (2024) |
| ABBVIE INC. | $829.03 | 39 | $0 (2024) |
| PFIZER INC. | $793.35 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $706.41 | 46 | $0 (2024) |
| Amgen Inc. | $675.43 | 39 | $0 (2023) |
| Incyte Corporation | $673.33 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $671.98 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,291 | 146 | PFIZER INC. ($301.10) |
| 2023 | $3,873 | 181 | Novartis Pharmaceuticals Corporation ($446.80) |
| 2022 | $3,767 | 156 | Novartis Pharmaceuticals Corporation ($556.04) |
| 2021 | $2,741 | 117 | NOVARTIS PHARMACEUTICALS CORPORATION ($966.43) |
| 2020 | $845.34 | 49 | Exelixis Inc. ($127.56) |
| 2019 | $2,715 | 160 | Merck Sharp & Dohme Corporation ($286.49) |
| 2018 | $2,214 | 134 | Novartis Pharmaceuticals Corporation ($397.14) |
| 2017 | $2,487 | 157 | Novartis Pharmaceuticals Corporation ($443.03) |
All Payment Transactions
1,100 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/09/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo, Tecentriq | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: BioOncology | ||||||
| 12/04/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Oncology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $62.40 | General |
| 11/15/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: HEMATOLOGY | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.50 | General |
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $37.73 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/23/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 85 | 9,061 | 203,353 | $9.1M | $2.9M |
| 2022 | 80 | 8,328 | 171,078 | $9.5M | $3.3M |
| 2021 | 102 | 11,144 | 243,421 | $9.9M | $4.4M |
| 2020 | 98 | 8,238 | 208,543 | $7.4M | $2.9M |
Total Patients
36,771
Total Services
826,395
Medicare Billing
$13.4M
Procedure Codes
365
All Medicare Procedures & Services
365 procedure records from CMS Medicare Utilization — Page 1 of 15
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 48 | 28,200 | $3.9M | $1.2M | 30.8% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 14 | 15,840 | $601,920 | $375,017 | 62.3% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2023 | 17 | 8,280 | $621,000 | $315,357 | 50.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 66 | 12,720 | $415,200 | $233,906 | 56.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 897 | 1,656 | $281,520 | $148,917 | 52.9% |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | Office | 2023 | 18 | 3,503 | $653,376 | $78,215 | 12.0% |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Office | 2023 | 11 | 6,450 | $129,000 | $65,240 | 50.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 254 | 696 | $272,832 | $64,386 | 23.6% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 44 | 38,985 | $116,955 | $33,747 | 28.9% |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | Office | 2023 | 15 | 288 | $169,920 | $32,025 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 390 | 535 | $69,572 | $31,471 | 45.2% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 31 | 4,934 | $123,350 | $28,595 | 23.2% |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 2023 | 12 | 1,250 | $93,750 | $26,134 | 27.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 1,078 | 2,573 | $69,471 | $19,497 | 28.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 847 | 1,831 | $58,592 | $18,923 | 32.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 37 | 135 | $121,230 | $16,846 | 13.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 100 | 114 | $24,510 | $14,620 | 59.7% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 25 | 80 | $49,920 | $14,263 | 28.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 184 | 294 | $54,390 | $13,124 | 24.1% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 49 | 78 | $73,866 | $12,361 | 16.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 162 | 551 | $69,440 | $11,269 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $19,952 | $9,749 | 48.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 417 | 603 | $28,944 | $7,983 | 27.6% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 90 | 168 | $32,760 | $7,692 | 23.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 316 | 416 | $39,936 | $6,103 | 15.3% |
About Dr. Harry Moore, M.D
Dr. Harry Moore, M.D is a Specialist healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1699096388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Moore, M.D has received a total of $21,933 in payments from pharmaceutical and medical device companies, with $3,291 received in 2024. These payments were reported across 1,100 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($19,130).
As a Medicare-enrolled provider, Moore has provided services to 36,771 Medicare beneficiaries, totaling 826,395 services with total Medicare billing of $13.4M. Data is available for 4 years (2020–2023), covering 365 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine, Medical Oncology
- Location Macon, GA
- Active Since 06/16/2010
- Last Updated 09/02/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1699096388
Products in Payments
- KISQALI (Drug) $1,587
- KEYTRUDA (Biological) $947.14
- IMBRUVICA (Drug) $709.14
- LIBTAYO (Biological) $656.85
- Xtandi (Drug) $371.20
- VENCLEXTA (Drug) $362.45
- XTANDI (Drug) $351.74
- Lenvima (Drug) $324.08
- DARZALEX (Biological) $308.22
- OXBRYTA (Drug) $286.67
- LYNPARZA (Drug) $265.69
- Enhertu (Drug) $251.62
- PROMACTA (Drug) $248.41
- JAKAFI (Drug) $246.30
- PIQRAY (Drug) $245.56
- Nubeqa (Drug) $238.11
- INJECTAFER (Drug) $223.22
- ZEJULA (Drug) $219.26
- MEKINIST (Drug) $216.11
- Imbruvica (Drug) $215.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Macon
Dr. Igor De Castro, M.d, M.D
Specialist — Payments: $485,775
Specialist $485,775
Frederick Schnell, M.d, M.D
Specialist — Payments: $178,972
Specialist $178,972
Bradley Sumrall, Md, MD
Specialist — Payments: $65,691
Specialist $65,691
Linda Hendricks, M.d, M.D
Specialist — Payments: $8,646
Specialist $8,646
Obinnaya Emerole, M.d, M.D
Specialist — Payments: $8,172
Specialist $8,172
Ahmad Al-Hajj, M.d, M.D
Specialist — Payments: $3,827
Specialist $3,827